Overview
Health and Human Services Secretary Robert F. Kennedy Jr. recently suggested that aluminum in childhood vaccines might be connected to the rise in peanut allergies. Public health experts say there is no credible scientific evidence to support that claim and warn that such a message could discourage parents from vaccinating their children.

What was said
At a Food Allergy Fund leadership forum, Kennedy questioned the idea that limited early exposure to peanuts explains increasing peanut allergy rates and proposed that the timing of aluminum use in vaccines could be involved. He also indicated his agency plans to study food allergies and their causes.

How scientists and clinicians respond
Pediatricians, allergists, and vaccinologists reject the idea that aluminum in vaccines causes peanut or other food allergies. They note multiple points: people are exposed to far more aluminum through food and the environment than through vaccines; aluminum salts have been used as vaccine adjuvants for many decades; and large population studies have not found links between vaccine aluminum and allergy outcomes.

Clinicians point out that aluminum has been used in most pediatric and adult vaccines for more than 80 years. If aluminum were a primary driver of food allergies, allergy rates would have shown a steady long-term increase over that entire period. Large-scale studies have not supported a connection between early-life aluminum exposure from vaccines and later development of food allergies.

Aluminum in vaccines and everyday exposure
Aluminum salts are added to some vaccines as adjuvants to boost immune response, allowing smaller amounts of antigen or fewer doses. Aluminum is also one of the most common elements in the environment, present in soil, water, food, and many consumer products.

Infants receive only small amounts of aluminum from vaccines — just over 4 mg in the first six months of life — and also ingest trace amounts from breast milk and formula. A large Danish study of 1.2 million children born 1997–2018 found no association between aluminum exposure from vaccines in the first two years and increased risk for any of 50 studied disorders, including food allergies.

Trends in peanut and food allergies
About 33 million people in the U.S. have a food allergy, roughly 1 in 10 adults and 1 in 13 children; peanut allergy affects an estimated ~2% of U.S. children. Rates increased notably around the turn of the century, with a 2010 report finding a tripling in peanut allergy between 1997 and 2008.

Changing medical guidance has influenced trends. Earlier recommendations to delay introducing allergenic foods were revised after the 2015 LEAP trial showed that introducing peanut-containing foods before age 1 substantially reduced the risk of peanut allergy by age 5. From about 2017, major medical organizations began recommending gradual early introduction of peanuts for many infants. An October study reported a decline in childhood peanut allergy after those guideline changes, from 0.92% before to 0.67% afterward, a roughly 27% reduction.

Peanut allergy has no single known cause
Researchers view peanut allergy as a multifactorial condition. Genetics, family history, other atopic conditions (like eczema), environmental exposures such as pollen, immune system development, and factors like vitamin D have all been implicated. Experts emphasize that allergy development cannot be pinned to a single cause such as aluminum in vaccines.

Why accurate messaging matters
Health professionals caution that linking vaccines to allergies without strong evidence could reduce vaccination rates. Vaccines protect against serious, sometimes fatal diseases such as measles and whooping cough; declining coverage undermines community protection and puts infants, pregnant people, the elderly, and immunocompromised individuals at greater risk.

Bottom line
Current evidence does not support a causal link between aluminum in vaccines and peanut or other food allergies. Aluminum has long been used as an adjuvant and is widespread in the environment; large studies have not found associations between vaccine aluminum exposure and increased allergy rates. Introducing peanut-containing foods early, following current medical guidance, has been associated with reductions in childhood peanut allergy prevalence.

Robert F. Kennedy Jr., the HHS secretary, recently suggested that aluminum in childhood vaccines might contribute to peanut allergies. Medical and public-health experts say there is no credible scientific evidence for that claim and worry such statements could discourage vaccination.

What was said
Kennedy questioned whether delayed peanut exposure explains peanut allergies and noted that aluminum began being used in vaccines around the time peanut allergies were observed to rise. He also said his agency plans to study the causes of food allergies.

What experts say
Pediatricians, allergists and researchers dispute the timeline and interpretation. They note that aluminum has been used as a vaccine adjuvant since 1926 to boost immune responses, and that it is widespread in the environment and diet. Clinicians point out that everyday exposure from food, drink and soil far exceeds what an infant receives from vaccines, and that aluminum has been used in most pediatric vaccines for many decades; if it were a cause of food allergies, the pattern of allergy emergence would not match the historical record.

A large July study of 1.2 million Danish children born 1997–2018 found no association between aluminum exposure from vaccines in the first two years of life and increased rates of any of 50 disorders studied, including food allergies. Other large studies similarly have not found a credible link between routine vaccinations and the development of allergies, including food allergies.

Aluminum in vaccines and typical exposure
Aluminum salts are included in some vaccines as adjuvants to strengthen the immune response so smaller amounts of antigen or fewer doses are needed. Aluminum is the third most abundant element in Earth’s crust and is present in many foods, beverages, consumer products and the environment. An infant receives a little over 4 mg of aluminum from recommended vaccines in the first six months of life; breast milk and formula also contain trace amounts.

Peanut allergy context
About 33 million people in the U.S. have a food allergy — roughly 1 in 10 adults and 1 in 13 children. Many report severe reactions, and some reactions can be life-threatening (anaphylaxis). Approximately 2% of U.S. children may have a peanut allergy, and up to about 20% of those children outgrow it.

Concerns about rising peanut allergies became prominent about two decades ago. A 2010 report found that peanut allergy prevalence in U.S. children tripled between 1997 and 2008. Earlier guidance had advised delaying introduction of allergenic foods, but by 2008 there was no convincing evidence that postponing introduction beyond six months prevented allergies.

Key trials and guideline changes
The 2015 LEAP (Learning Early About Peanut allergy) randomized trial showed that introducing peanut-containing foods before a child’s first birthday significantly reduced the risk of peanut allergy by age 5. That evidence prompted a change in clinical guidance: beginning around 2017, pediatricians and allergy specialists began recommending gradual introduction of age-appropriate peanut foods to many infants. An October study found U.S. childhood peanut allergy rates fell after these guidelines, from 0.92% to 0.67% — a 27% reduction over a two-year observation period, which experts view as notable evidence that early introduction helps reduce risk for many children.

Causes are multifactorial
Researchers do not fully understand why individual children develop peanut or other food allergies. Risk factors may include personal or family history of allergies, eczema or compromised skin barrier, genetic predisposition, aspects of immune development, and environmental influences such as vitamin D status or pollen exposure. Early introduction of peanut can reduce risk for many infants but is not a complete solution for all children, especially those prone to multiple food allergies.

Public-health implications
Physicians emphasize the importance of routine childhood vaccination to prevent serious, sometimes deadly infectious diseases such as measles. Declining vaccination rates increase the risk of outbreaks and weaken community protection, placing vulnerable groups — infants, pregnant people, the elderly and the immunocompromised — at greater risk.

Bottom line
Current scientific evidence does not support a causal link between aluminum in vaccines and peanut or other food allergies. Aluminum has been used as a vaccine adjuvant for many decades and is ubiquitous in the environment and diet. Large population studies have not found an association between vaccine aluminum exposure and higher allergy risk. Randomized trials and subsequent guideline changes indicate that early, supervised introduction of peanut-containing foods can reduce the risk of peanut allergy in many children, but the development of food allergies remains complex and influenced by multiple factors.